Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(1.68)
# 3,399
Out of 5,090 analysts
207
Total ratings
22.17%
Success rate
-8.43%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.05 | +757.14% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $0.38 | +2,021.45% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $5.33 | +256.47% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $1.31 | +205.34% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $3.19 | -37.30% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $200 | $7.24 | +2,662.43% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $2.36 | +705.08% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $1.76 | +1,093.18% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $1.23 | +1,119.51% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $560 | $3.70 | +15,035.14% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $6.79 | +1,667.30% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $6.62 | +504.23% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $1.84 | +1,530.43% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $6.91 | +174.96% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.58 | +912.66% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.95 | +531.58% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.18 | +8,374.58% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.31 | +5,650.80% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.22 | +800.90% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $5.96 | +264,161.74% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $16.66 | +2,901.20% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $27.35 | +777.51% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.32 | +5,960.61% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,500 | $4.26 | +35,111.27% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $9.65 | +82,801.55% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.31 | +434.35% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $1.88 | +1,495.74% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $4.62 | +765.80% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $6.45 | +179.07% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $5.74 | -12.89% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $10.93 | +13,074.75% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $65.67 | -63.45% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $1.12 | +305,257.14% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $1.20 | +1,583,233.33% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.05
Upside: +757.14%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $0.38
Upside: +2,021.45%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $5.33
Upside: +256.47%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $1.31
Upside: +205.34%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $3.19
Upside: -37.30%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $200
Current: $7.24
Upside: +2,662.43%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $2.36
Upside: +705.08%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $1.76
Upside: +1,093.18%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.23
Upside: +1,119.51%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $560
Current: $3.70
Upside: +15,035.14%
Mar 6, 2025
Reiterates: Buy
Price Target: $120
Current: $6.79
Upside: +1,667.30%
Mar 5, 2025
Reiterates: Buy
Price Target: $40
Current: $6.62
Upside: +504.23%
Mar 4, 2025
Reiterates: Buy
Price Target: $30
Current: $1.84
Upside: +1,530.43%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $6.91
Upside: +174.96%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $1.58
Upside: +912.66%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.95
Upside: +531.58%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $1.18
Upside: +8,374.58%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $0.31
Upside: +5,650.80%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.22
Upside: +800.90%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $5.96
Upside: +264,161.74%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $16.66
Upside: +2,901.20%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $27.35
Upside: +777.51%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $1.32
Upside: +5,960.61%
Jun 30, 2021
Initiates: Buy
Price Target: $1,500
Current: $4.26
Upside: +35,111.27%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $9.65
Upside: +82,801.55%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.31
Upside: +434.35%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $1.88
Upside: +1,495.74%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $4.62
Upside: +765.80%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $6.45
Upside: +179.07%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $5.74
Upside: -12.89%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $10.93
Upside: +13,074.75%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $65.67
Upside: -63.45%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $1.12
Upside: +305,257.14%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $1.20
Upside: +1,583,233.33%